The latest news from academia, regulators
research labs and other things of interest
Posted: August 6, 2008
Bio Nano Consulting and Oxford Immunotec Work Together to Improve Infectious Disease Diagnosis and Monitoring
(Nanowerk News) Bio Nano Consulting (BNC), a specialist bionanotechnology
product development consultancy, announced that it has
commenced a project with international T cell measurement company, Oxford
Immunotec. BNC is applying its expertise in nano-characterisation to assist Oxford
Immunotec in a project related to its novel Enzyme-Linked ImmunoSPOT (ELISPOT)
system. As specialists in bio-nanotechnology, BNC is able to utilise the world-leading
nano-characterisation facilities at the Institute of Biomedical Engineering, Imperial
Oxford Immunotec is commercialising a diagnostic test to detect tuberculosis (TB)
based on its patented T-SPOT technology, effectively providing a new way to diagnose
and monitor this deadly disease. The World Health Organization (WHO) has estimated
that almost 1.6 million deaths resulted worldwide from TB in 2005.
The developing field of bio-nanotechnology promises great advances in medicine,
particularly in the areas of diagnostics and therapeutics. By collaborating with Oxford
Immunotec, BNC are facilitating the development of precise, accurate techniques to
diagnose and monitor infection and disease.
About Bio Nano Consulting
The BNC is a specialist research and development consultancy operating in the convergent field of
bionanotechnology. A joint venture of Imperial College London and University College London, the BNC is
funded through the Technology Strategy Board (TSB) with additional support from the London Development
Along with its partner organisation, the National Physical Laboratory (NPL), the BNC offers a service to the
biomedical and healthcare industries in microsystems and nanotechnology. This encompasses design, 3-D
modelling and visualisation, rapid prototyping, and characterisation.
For more information please see: www.bio-nano-consulting.com
About Oxford Immunotec
Oxford Immunotec, the T cell measurement company is based in Oxford, UK and Marlborough, MA. The
Company develops and sells clinical diagnostic products based on its patented T-SPOT® technology, the first
regulatory approved method for directly quantifying antigen-specific T cells. T-SPOT is a simple and
extremely accurate method of studying a personís cellular immune response to infection and can be applied
to diagnose and monitor any major disease driven by a T cell response.
T-SPOT® is a trademark of Oxford Immunotec.
For more information please see: www.oxfordimmunotec.com